Salvatore Rizza Selected Research

Salvatore Rizza Research Topics

12	Neoplasms (Cancer) 01/2023 - 01/2012
2	Melanoma (Melanoma, Malignant) 01/2021 - 01/2021
2	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 01/2016
2	Carcinogenesis 01/2016 - 01/2012
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022
1	Progeria (Hutchinson Gilford Syndrome) 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Premature Aging 01/2022
1	Laminopathies 01/2022
1	Genomic Instability 01/2021
1	Ischemia 01/2020
1	Parkinson Disease (Parkinson's Disease) 01/2015
1	Hypoxia (Hypoxemia) 01/2015
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2015
1	Atrophy 08/2014

4	EnzymesIBA 01/2023 - 01/2015
4	glutathione-independent formaldehyde dehydrogenase (formaldehyde dehydrogenase)IBA 01/2023 - 01/2015
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2012
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2023 - 08/2014
2	Focal Adhesion Kinase 1IBA 01/2023 - 01/2021
2	Succinic Acid (Succinate)IBA 01/2020 - 01/2016
2	S-NitrosothiolsIBA 08/2014 - 01/2012
1	ElementsIBA 01/2023
1	SuspensionsIBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Auranofin (Ridaura)FDA Link 01/2022
1	ChromatinIBA 01/2022
1	ProteomeIBA 01/2022
1	Lamin Type A (Lamin A)IBA 01/2022
1	PhytochemicalsIBA 01/2021
1	VemurafenibIBA 01/2021
1	Retinoblastoma ProteinIBA 01/2021
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2021
1	Cyclin DIBA 01/2021
1	Oncogene Proteins (Oncogene Protein)IBA 10/2020
1	Cysteine (L-Cysteine)FDA Link 01/2020
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2016
1	Protein SIBA 01/2016
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2016
1	cobaltous chloride (cobalt(II)chloride)IBA 01/2015
1	Tyrosine (L-Tyrosine)FDA Link 08/2014
1	Glutamine (L-Glutamine)FDA Link 09/2012
1	Pyruvic Acid (Pyruvate)IBA 09/2012
1	bromopyruvateIBA 09/2012

2	Therapeutics 01/2021 - 10/2020
1	Drug Therapy (Chemotherapy) 09/2012